Prostate cancer research and the National Cancer Institute.
The National Cancer Institute (NCI) is the largest funder of prostate cancer research in the United States and indeed the world. It is sponsoring a number of studies to answer the significant questions pertinent to prostate cancer and pertinent to black men. These include studies of epidemiology; cancer prevention, screening, and control; clinical treatment; and basic science. In addition, the NCI is charged with dissemination of research findings to physicians and the lay public. The following is a description of the NCI prostate cancer research portfolio including the scientific questions being addressed and how are they being addressed.
Brawley
O W
OW
Office of Special Populations Research, National Cancer Institute, Bethesda, MD 20892, USA.
Figueroa-Valles
N
N
D001741:Black or African American; D002986:Clinical Trials as Topic; D006801:Humans; D007255:Information Services; D008297:Male; D009316:National Institutes of Health (U.S.) / Q000458:organization & administration*; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000208:ethnology / Q000209:etiology; D012109:Research Support as Topic; D018426:SEER Program; D014481:United States / Q000453:epidemiology